What smart money is saying about Cryoport
CYRX
No fund has written a full thesis on Cryoport in our archive, but 1 fund letter reports a position in it — most recently Granahan Investment Management Focused Growth Strategy in September 2026.
Get an email when a fund buys, sells or pitches it
1
Reported positions
1
Bought
0
Sold
1
Letter
Position history
Every position in Cryoport on record in the archive was reported in Q3 2026, across 1 fund letter, with 1 buy (opened or added).
| Quarter | Letters | Bought | Sold | Theses |
|---|---|---|---|---|
| Q3 2026 | 1 | 1 | 0 | 0 |
Bought and Sold count moves: the same sentence published by several funds of one house in a quarter counts once.
Fund activity · 1 position · 1 move
- September 2026
“Given the strong moves, we trimmed TWST and GRAL and started a new position in Cryoport (CYRX), which provides temperature-controlled logistics and storage for cell and gene therapies and should benefit as those therapies expand.”
Cryoport
Read the letters behind these Cryoport positions
Every quote above comes from a fund letter in our archive. Get unlimited access to the letters themselves — and to Warren AI, which reads all of them for you.
View plans→Share this ledger